Pushing scientific and business frontiers
Cambridge has been at the forefront of technology and life sciences innovation for centuries and is still forging ahead. The historic success of Cambridge in advancing scientific and business frontiers is the subject of an article in IQ, a magazine…
Cambridge Independent: Life sciences and IT drove Cambridge growth in pandemic’s first year
New data covering the first full year of the pandemic (April 2020 to March 2021) identifies the life sciences and IT sectors as driving growth in the region. The analysis from the Centre for Business Research (CBR) at Cambridge Judge…
Biopharm expansion
Apollo Therapeutics, a life sciences company led by Cambridge Judge Business School alumnus and Fellow Dr Richard Mason, completes $145 million financing. Apollo Therapeutics, a biopharmaceutical company headed by Cambridge Judge Business School MBA alumnus and Fellow Dr Richard Mason…
Growth recognition
Cambridge Healthcare Research, co-founded by Cambridge MBA alumnus Max Rubin (MBA 2010), awarded Queen's Award for Enterprise. Cambridge Healthcare Research Ltd, a firm whose Founding Partner is Cambridge MBA graduate Max Rubin (MBA 2010), was awarded a Queen's Award for…
China Medical System (CMS) to invest up to £25 million to support early stage biotech firms in the UK with a Cambridge focus
CMS, a speciality pharmaceutical company listed on the Hong Kong Stock Exchange, has signalled its confidence in the UK biotech and life sciences sectors through intended investment in early stage UK biotech and life sciences businesses, with support from AstraZeneca…
Grant for LIFNanoRx
Venture that fights Multiple Sclerosis through 'NanoMedicine', supported by Cambridge Judge Business School, gets £1 million new funding. LIFNanoRx, a venture supported by Cambridge Judge that fights Multiple Sclerosis (MS), will receive £1 million to support its pioneering global solution…
Saira Ramasastry, Managing Partner of Life Sciences Advisory
As a big player in the biotech community, Saira Ramasastry says doing well and doing good aren't necessarily mutually exclusive, and that in business you can't be afraid of failure. I take a 'servant leadership' approach. My starting objective is…
AstraZeneca and Cambridge Judge Business School announce collaboration to identify and support biotech start-ups
AstraZeneca and the University of Cambridge Judge Business School today announced an agreement to deliver a new "Accelerate Cambridge Life Sciences" programme at the business school which will identify, train and mentor start-up ventures in the life sciences. The partnership…
